Younger Patients Less Likely to Die From NMIBC
The investigators found no significant age-related differences in survival from muscle-invasive bladder cancer.
The investigators found no significant age-related differences in survival from muscle-invasive bladder cancer.
Decrease seen for 11 of the 19 most common cancers among men and for 14 of the 20 most common cancers among women.
In high treatment benefit category, Black men less likely to receive definitive treatment than non-Black men.
Black patients were more likely than White patients to have distant metastases.
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
Black patients were less likely to have EGFR and BRAF mutations as well as ALK alterations.
Patients living in states with lower eligibility limits had worse survival rates, regardless of cancer stage at diagnosis.
Compared with absolute PSA, PSA velocity associated more with increased likelihood of progression among men on active surveillance for prostate cancer.
Screening intensity was predictive of disease stage and mortality risk.
GPS can predict adverse outcomes in men with prostate cancer and may be used to select patients for active surveillance rather than active treatment.